Patents by Inventor Barry Clements

Barry Clements has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR REDUCING LUNG INFLAMMATION
    Publication number: 20230045633
    Abstract: A method of treating or preventing inflammation in the lung by administering a high concentration of an inhaled chelating agent.
    Type: Application
    Filed: September 28, 2022
    Publication date: February 9, 2023
    Inventor: Barry Clements
  • Method for reducing lung inflammation
    Patent number: 11491126
    Abstract: A method of treating or preventing inflammation in the lung by administering a high concentration of an inhaled chelating agent.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: November 8, 2022
    Assignee: Respirion Pharmaceuticals PTY LTD
    Inventor: Barry Clements
  • Method for reducing lung infection
    Patent number: 11382884
    Abstract: A method of treating or preventing a bacterial infection in the lung of a subject by administering an inhaled antibiotic, and at least 37.5 mg/day of an inhaled chelating agent, each in one or more doses, wherein the or each dose of the chelating agent and/or antibiotic is administered over a period of no more than 8h.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: July 12, 2022
    Assignee: Respirion Pharmaceuticals PTY LTD
    Inventor: Barry Clements
  • METHOD FOR REDUCING LUNG INFLAMMATION
    Publication number: 20200163920
    Abstract: A method of treating or preventing inflammation in the lung by administering a high concentration of an inhaled chelating agent.
    Type: Application
    Filed: June 20, 2018
    Publication date: May 28, 2020
    Inventor: Barry Clements
  • METHOD FOR REDUCING LUNG INFECTION
    Publication number: 20200108033
    Abstract: A method of treating or preventing a bacterial infection in the lung of a subject by administering an inhaled antibiotic, and at least 37.5 mg/day of an inhaled chelating agent, each in one or more doses, wherein the or each dose of the chelating agent and/or antibiotic is administered over a period of no more than 8h.
    Type: Application
    Filed: June 20, 2018
    Publication date: April 9, 2020
    Inventor: Barry Clements